Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.

Vision AI is a cutting-edge, AI-driven platform that can detect diabetic retinopathy and other retinal diseases with high accuracy and speed using retinal scans, as well as diseases unrelated to ...

Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging technology company developing healthcare solutions using both artificial intelligence (AI) and developments in ...

Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies By Avant Technologies Inc. Jun 17, 2025 Updated Jun 17, 2025 ...

With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead.

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- USA News Group News Commentary - This week in Geneva, the World Health ...

Vision AI is a cutting-edge, AI-driven platform that can detect diabetic retinopathy and other retinal diseases with high accuracy and speed using retinal scans, as well as diseases unrelated to ...

Coding is outsourced to IT companies in Nepal because it is cheap, and there is a large pool of coders with 15,000 graduates ...

Malaysia began incorporating AI screening as early as 2020, when private healthcare centres launched initiatives to use AI ...

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- Several experts are seeing that value of AI's total overhaul ...

Artificial Intelligence (AI) technology co-developed by DeepMind and Moorfields Eye Hospital in London shows a potential to work alongside ophthalmologists to accelerate the diagnosis and help to ...